Information  X 
Enter a valid email address

Arix Bioscience PLC 0.001P (ARIX)

Date Time Source Announcement
13 Apr 2021 5:13 pm
EQS
Transaction in own shares
12 Apr 2021 5:22 pm
EQS
Transaction in own shares
09 Apr 2021 5:43 pm
EQS
Transaction in own shares
08 Apr 2021 5:27 pm
EQS
Transaction in own shares
  8:19 am
RNS
Proactive One2One Virtual Investor Forum
  7:00 am
EQS
Arix to Present at the Proactive One2One Virtual Investor Forum
07 Apr 2021 5:46 pm
EQS
Transaction in own shares
  7:00 am
EQS
Artios announces collaboration with Novartis to create next generation DDR cancer therapies
06 Apr 2021 5:25 pm
EQS
Transaction in own shares
01 Apr 2021 5:19 pm
EQS
Transaction in own shares
  7:00 am
EQS
Total Voting Rights
31 Mar 2021 5:38 pm
EQS
Transaction in own shares
30 Mar 2021 5:08 pm
EQS
Transaction in own shares
  1:01 pm
EQS
Arix leads $152 million Series B financing for Pyxis Oncology
  7:00 am
EQS
Gita Dittmar appointed as Venture Partner
29 Mar 2021 5:14 pm
EQS
Transaction in own shares
  7:00 am
EQS
Board update
26 Mar 2021 5:14 pm
EQS
Transaction in own shares
25 Mar 2021 4:57 pm
EQS
Transaction in own shares
24 Mar 2021 5:04 pm
EQS
Transaction in own shares
  7:00 am
EQS
Strategy Implementation Review
23 Mar 2021 5:27 pm
EQS
Transaction in own shares
22 Mar 2021 5:57 pm
EQS
Transaction in own shares
  11:09 am
EQS
Aura Biosciences announces oversubscribed $80 million financing
  7:00 am
EQS
Share buyback programme of up to �25 million
19 Mar 2021 4:00 pm
EQS
Holding(s) in Company
15 Mar 2021 7:30 am
EQS
Arix Bioscience (ARIX): 32% IRR since inception in 2016
  7:00 am
EQS
Share buyback programme of up to �25 million
10 Mar 2021 7:00 am
EQS
Response to Activist Shareholder Acacia
09 Mar 2021 7:01 am
EQS
Arix founds new portfolio company Twelve Bio
  7:00 am
EQS
Annual Results for the Twelve Months ended 31 December 2020
25 Feb 2021 7:00 am
EQS
Board Changes
15 Feb 2021 9:00 am
EQS
Holding(s) in Company
11 Feb 2021 7:00 am
EQS
Notice of Results
10 Feb 2021 9:00 am
EQS
Autolus announces pricing of public offering
05 Feb 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
18 Jan 2021 7:00 am
EQS
Investment team changes
12 Jan 2021 7:00 am
EQS
Harpoon announces closing of public offering
06 Jan 2021 2:00 pm
EQS
Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease
  10:00 am
EQS
Autolus provides business outlook for 2021 and 2022
31 Dec 2020 9:00 am
RNS
Price Monitoring Extension
21 Dec 2020 7:00 am
EQS
Director Share Purchase
18 Dec 2020 8:00 am
EQS
Completion of sale of VelosBio
11 Dec 2020 7:00 am
EQS
Atox Bio announces FDA acceptance of New Drug Application
08 Dec 2020 3:45 pm
EQS
Harpoon reports clinical progress across all pipeline development programmes
07 Dec 2020 5:47 pm
EQS
Autolus presents additional data on AUTO3 at ASH
  7:15 am
EQS
Arix Bioscience (ARIX): Artios attracts Merck KGaA in deal up to $7bn
  7:00 am
EQS
Autolus presents positive AUTO1 data at ASH
04 Dec 2020 7:01 am
EQS
Holding(s) in Company
  7:00 am
EQS
Holding(s) in Company
03 Dec 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  8:01 am
EQS
Artios and Merck KGaA announce global strategic collaboration
12 Nov 2020 7:00 am
EQS
Arix to Present at the Jefferies Virtual London Healthcare Conference
06 Nov 2020 12:10 pm
EQS
Arix Bioscience (ARIX): Hitting the jackpot
05 Nov 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t